CNN — More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation’s two other major insulin manufacturers in offering either price caps or savings programs that lower the cost of the drugs to $35 for many patients. The three drugmakers are also drastically lowering the list prices for their products. The moves were announced in the spring, but some didn’t take effect until January 1. Drugmakers have come under fire for years for steeply raising the ...